Aligos Therapeutics, Inc. (ALGS) closed the last trading session at $14.48, gaining 5.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $108.33 indicates a 648.1% upside potential.The mean estimate comprises three short-term price targets with a standard deviation of $57.74. While the lowest estimate of $75 indicates a 418% increase from the current price level, the most optimisti ...